(Q44131778)

English

A randomized study comparing low dose ciprofloxacin and ofloxacin in the treatment of lower respiratory tract infections

scientific article published in January 1994

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

A randomized study comparing low dose ciprofloxacin and ofloxacin in the treatment of lower respiratory tract infections (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

1 reference

based on heuristic

inferred from title

author name string

A Polubiec

1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

I Jórasz

2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

J Pietrzak

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

A Soszka

4

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

K Stepka

5

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

A Zaryn

6

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

publication date

1 January 1994

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

62-64

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

https://scigraph.springernature.com/pub.10.1007/bf01780772

0 references

Bacterial infections of the lower urinary tract treated with ciprofloxacin or cefalexin--a comparative study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8181847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/8181847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Evaluation of the effect of new fluoroderivatives of piperazinol-quinoline on clinical strains of aerobic and anaerobic bacteria]

1 reference

https://pubmed.ncbi.nlm.nih.gov/8181847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral ciprofloxacin therapy of infections due to Pseudomonas aeruginosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/8181847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms of action of and resistance to ciprofloxacin

1 reference

https://pubmed.ncbi.nlm.nih.gov/8181847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of ciprofloxacin therapy in urinary and respiratory tract infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/8181847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF01780772

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44131778&oldid=2106924915"